A dopamine D3 receptor partial agonist blocks the expression of conditioned activity

被引:26
作者
Aujla, H
Sokoloff, P
Beninger, RJ [1 ]
机构
[1] Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada
[2] Queens Univ, Dept Psychiat, Kingston, ON K7L 3N6, Canada
[3] Ctr Paul Broca, INSERM, U109, Unite Neurobiol & Pharmacol Mol, F-75014 Paris, France
关键词
amphetamine; BP; 897; conditioned activity; D3; receptors; dopamine; drug seeking; relapse;
D O I
10.1097/00001756-200201210-00039
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The partial dopamine D3 receptor agonist BP 897 attenuates cocaine seeking suggesting that BP 897 will attenuate conditioned activity to environmental stimuli paired with amphetamine. During conditioning, amphetamine (2.0 mg/kg) stimulated activity and co-treatment with BP 897 (1.0 mg/kg) had no effect. In the saline test, groups conditioned with amphetamine or amphetamine plus BP 897 showed conditioned activity. Treatment with BP 897 in the test following conditioning with saline produced no significant effect but following conditioning with amphetamine BP 897 blocked conditioned activity. Results extend previous findings that BP 897 attenuates responding for cocaine-paired stimuli to amphetamine-paired stimuli in a different paradigm and support the potential of BP 897 as a therapeutic agent for the prevention of drug seeking. NeuroReport 13:173-176 (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:173 / 176
页数:4
相关论文
共 23 条
[21]   The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors [J].
Wicke, K ;
Garcia-Ladona, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 424 (02) :85-90
[22]   STRIATAL DOPAMINE IN MOTOR ACTIVATION AND REWARD-MEDIATED LEARNING - STEPS TOWARDS A UNIFYING MODEL [J].
WICKENS, J .
JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1990, 80 (01) :9-31
[23]   Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor [J].
Wood, MD ;
Boyfield, I ;
Nash, DJ ;
Jewitt, FR ;
Avenell, KY ;
Riley, GJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 407 (1-2) :47-51